文献速递间质性肺疾病慢阻肺

过敏性肺炎的影像学表型与生存时间和肺功能轨迹的关联

Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.
PubMed 文献 · Chest · 2018-09-19

本研究比较了过敏性肺炎(HP)与特发性肺纤维化(IPF)患者按影像学表型分组的生存时间和肺功能轨迹。结果显示HP可分为三种预后不同的影像学表型:无纤维化HP生存期最长且FVC%预计值改善,非蜂窝状纤维化HP生存期优于IPF但FVC%下降,蜂窝状改变者(HP和IPF)生存期均差且FVC%显著下降。

要点

  • 无纤维化HP患者中位生存期超过14.73年,FVC%预计值改善。
  • 非蜂窝状纤维化HP患者生存期优于IPF,但FVC%预计值均显著下降。
  • 存在蜂窝状改变时,HP和IPF患者生存期均差,有创诊断价值有限。

核心结论

  • HP患者可按影像学分为三种预后不同的表型:无纤维化、非蜂窝状纤维化和蜂窝状改变,其生存时间和肺功能轨迹各异。
  • 在非蜂窝状纤维化患者中,明确HP与IPF的诊断具有重要意义,因两者生存期不同。
  • 当影像学出现蜂窝状改变时,针对确定诊断的有创检查可能价值有限,因预后均差。

研究设计与样本

  • 研究纳入HP患者117例(经外科/经支气管肺活检、BAL和暴露史诊断)和IPF患者152例(临床和组织病理学诊断)。
  • 所有参与者均有基线高分辨率CT(HRCT)扫描和FVC%预计值,由三名胸部放射科医生记录影像学特征。
  • 生存时间从HRCT扫描至死亡或肺移植,采用Cox比例风险模型分析相关变量,线性混合模型比较HRCT后FVC%预计值轨迹。

主要发现

  • 无纤维化HP患者中位无事件生存期最长(>14.73年),FVC%预计值改善(1.92%;95%CI,0.49-3.35;P=.009)。
  • 非蜂窝状纤维化HP患者生存期长于IPF患者(>7.95年 vs 5.20年),两组FVC%预计值均显著下降。
  • 蜂窝状改变的HP和IPF患者生存期均差(分别为2.76年和2.81年),FVC%预计值显著下降。

关键数值与推荐

  • HP诊断基于外科/经支气管肺活检、BAL和暴露史结果综合判断。
  • IPF诊断基于临床和组织病理学标准。
  • 影像学表型分为三组:蜂窝状改变、非蜂窝状纤维化(牵拉性支气管扩张和网状影)和无纤维化。

临床怎么用

  • 对于非蜂窝状纤维化患者,应积极明确HP与IPF的诊断,因两者预后不同。
  • 影像学出现蜂窝状改变时,有创诊断检查可能价值有限,可考虑减少侵入性操作。
  • 根据影像学表型可对HP患者进行预后分层,指导临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypersensitivity pneumonitis (HP) is an interstitial lung disease with a better prognosis, on average, than idiopathic pulmonary fibrosis (IPF). We compare survival time and pulmonary function trajectory in patients with HP and IPF by radiologic phenotype. METHODS: HP (n = 117) was diagnosed if surgical/transbronchial lung biopsy, BAL, and exposure history results suggested this diagnosis. IPF (n = 152) was clinically and histopathologically diagnosed. All participants had a baseline high-resolution CT (HRCT) scan and FVC % predicted. Three thoracic radiologists documented radiologic features. Survival time is from HRCT scan to death or lung transplant. Cox proportional hazards models identify variables associated with survival time. Linear mixed models compare post-HRCT scan FVC % predicted trajectories. RESULTS: Subjects were grouped by clinical diagnosis and three mutually exclusive radiologic phenotypes: honeycomb present, non-honeycomb fibrosis (traction bronchiectasis and reticulation) present, and nonfibrotic. Nonfibrotic HP had the longest event-free median survival (> 14.73 years) and improving FVC % predicted (1.92%; 95% CI, 0.49-3.35; P = .009). HP with non-honeycomb fibrosis had longer survival than IPF (> 7.95 vs 5.20 years), and both groups experienced a significant decline in FVC % predicted. Subjects with HP and IPF with honeycombing had poor survival (2.76 and 2.81 years, respectively) and significant decline in FVC % predicted. CONCLUSIONS: Three prognostically distinct, radiologically defined phenotypes are identified among patients with HP. The importance of pursuing a specific diagnosis (eg, HP vs IPF) among patients with non-honeycomb fibrosis is highlighted. When radiologic honeycombing is present, invasive diagnostic testing directed at determining the diagnosis may be of limited value given a uniformly poor prognosis.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Salisbury ML, Gu T, Murray S, et al. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory. Chest. 2018. PMID: 30243979. doi:10.1016/j.chest.2018.08.1076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。